Showing results (81-90 of 764) with videos related to

Sort By:
Pageof 77
JAMA Network Open|December 28, 2020
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the USSamuel L Washington, Chang Wook Jeong, Peter E Lonergan, et al.
The Journal of Urology|April 27, 2019
A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active SurveillanceZachary Kornberg, Matthew R Cooperberg, Janet E Cowan, et al.
The Journal of Urology|March 11, 2005
Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSUREJoseph A Mitchell, Matthew R Cooperberg, Eric P Elkin, et al.
The Journal of Urology|October 9, 2003
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURESusan R Harlan, Matthew R Cooperberg, Eric P Elkin, et al.
The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.
Cancer|September 8, 2017
The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomyChristopher J Welty, Thomas H Sanford, Jonathan L Wright, et al.
Pageof 77